Bulk Manufacturer of Controlled Substances Application: Cambrex High Point, Inc., 61795-61796 [2017-28177]

Download as PDF Federal Register / Vol. 82, No. 249 / Friday, December 29, 2017 / Notices DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—Network Centric Operations Industry Consortium, Inc. Notice is hereby given that, on December 5, 2017, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Network Centric Operations Industry Consortium, Inc. (‘‘NCOIC’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Marc Fiammante (individual member), Alpes Maritimes, FRANCE, has been added as a party to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and NCOIC intends to file additional written notifications disclosing all changes in membership. On November 19, 2004, NCOIC filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on February 2, 2005 (70 FR 5486). The last notification was filed with the Department on July 11, 2017. A notice was published in the Federal Register pursuant to Section 6(b) of the Act on August 15, 2017 (82 FR 38711). comments on or objections to the issuance of the proposed registration on or before February 27, 2018. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.33(a), this is notice that on October 28, 2016, AMPAC Fine Chemicals Virginia, LLC, 2820 North Normandy Drive, Petersburg, Virginia 23805–2380 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances: Controlled substance Drug code Methylphenidate ... Levomethorphan ... Levorphanol .......... 1724 9210 9220 Schedule II II II The company plans to manufacture the listed controlled substances in bulk for distribution to its customers. Dated: December 15, 2017. Demetra Ashley, Acting Assistant Administrator. [FR Doc. 2017–28129 Filed 12–28–17; 8:45 am] [FR Doc. 2017–28178 Filed 12–28–17; 8:45 am] BILLING CODE P BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE DEPARTMENT OF JUSTICE Drug Enforcement Administration Drug Enforcement Administration [Docket No. DEA–392] ethrower on DSK3G9T082PROD with NOTICES Patricia A. Brink, Director of Civil Enforcement, Antitrust Division. [Docket No. DEA–392] Bulk Manufacturer of Controlled Substances Application: AMPAC Fine Chemicals LLC Importer of Controlled Substances Application: ABBVIE LTD; Correction ACTION: ACTION: Notice of application. VerDate Sep<11>2014 20:09 Dec 28, 2017 Jkt 244001 The Drug Enforcement Administration (DEA) published a document in the Federal Register of December 1, 2017, concerning a notice SUMMARY: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written DATES: Notice; correction. PO 00000 Frm 00068 Fmt 4703 Sfmt 4703 61795 of application that inadvertently misstated what the firm plans to do with imported tapentadol. Correction In the Federal Register of December 1, 2017, in FR Doc. 2017–25921 (82 FR 230), on page 230, in the second column, the last paragraph, correct the first sentence to read: The company plans to import bulk tapentadol (9780) to manufacture dosage form tapentadol (9780) for distribution to its customers. Demetra Ashley, Acting Assistant Administrator. [FR Doc. 2017–28176 Filed 12–28–17; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Bulk Manufacturer of Controlled Substances Application: Cambrex High Point, Inc. ACTION: Notice of application. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before February 27, 2018. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.33(a), this is notice that on November 22, 2016, Cambrex High Point, Inc., 4180 Mendenhall Oaks Parkway, High Point, North Carolina 27265 applied to be registered as a bulk DATES: E:\FR\FM\29DEN1.SGM 29DEN1 61796 Federal Register / Vol. 82, No. 249 / Friday, December 29, 2017 / Notices manufacturer of the following basic classes of controlled substances: Controlled substance Drug code Oxymorphone ....... Noroxymorphone .. 9652 9668 Schedule II II The company plans to manufacture the above-listed controlled substances in bulk for distribution to its customers. Dated: December 15, 2017. Demetra Ashley, Acting Assistant Administrator. [FR Doc. 2017–28177 Filed 12–28–17; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE ethrower on DSK3G9T082PROD with NOTICES Notice of Lodging of Proposed Consent Decree Under the Clean Air Act To submit comments: On December 22, 2017, the Department of Justice lodged a proposed Consent Decree with the United States District Court for the Middle District of Louisiana in the lawsuit entitled United States et al. v. Sid Richardson Carbon, LTD., (M.D. La.), Civil Case. No. 3:17-cv01792–SDD–RLB. In this civil enforcement action under the federal Clean Air Act (‘‘Act’’), the United States, the Louisiana Department of Environmental Quality, and the State of Texas allege that Sid Richardson Carbon, LTD. (‘‘Defendant’’), failed to comply with certain requirements of the Act intended to protect air quality at three carbon black manufacturing facilities in Addis, Louisiana and Borger and Big Spring, Texas. The complaint seeks injunctive relief and civil penalties for violations of the Clean Air Act’s Prevention of Significant Deterioration (‘‘PSD’’) provisions, 42 U.S.C. 7470–92; the Act’s Nonattainment New Source Review provisions, 42 U.S.C. 7501–7515; the Act’s National Emissions Standards for Hazardous Air Pollutants, 42 U.S.C. 7412; and various Clean Air Act implementing regulations. The complaint alleges that Defendant failed to obtain appropriate permits and failed to install and operate required pollution control devices to reduce emissions of sulfur dioxide (‘‘SO2’’), nitrogen oxides (‘‘NOX’’), and/or particulate matter (‘‘PM’’) at the Addis, Borger, and Big Spring facilities. The proposed Consent Decree would resolve violations for certain provisions of the Act at the three facilities, and would require the Defendant to reduce harmful SO2, NOX, and PM emissions through the installation and operation of VerDate Sep<11>2014 20:09 Dec 28, 2017 Jkt 244001 pollution controls. The Defendant will also spend $490,000 to fund environmental mitigation projects that will further reduce emissions and benefit communities adversely affected by the pollution from the facilities, and pay a civil penalty of $999,000. The publication of this notice opens a period for public comment on the proposed Consent Decree. Comments should be addressed to the Assistant Attorney General, Environment and Natural Resources Division, and should refer to United States et al. v. Sid Richardson Carbon, LTD., (M.D. La.), D.J. Ref. No. 90–5–2–1–10663. All comments must be submitted no later than thirty (30) days after the publication date of this notice. Comments may be submitted either by email or by mail: Send them to: By email ....... pubcomment-ees.enrd@ usdoj.gov Assistant Attorney General, U.S. DOJ—ENRD, P.O. Box 7611, Washington, D.C. 20044–7611. By mail ......... During the public comment period, the proposed Consent Decree may be examined and downloaded at this Justice Department website: http:// www.usdoj.gov/enrd/consent-decrees. The Justice Department will provide a paper copy of the proposed Consent Decree upon written request and payment of reproduction costs. Please mail your request and payment to: Consent Decree Library, U.S. DOJ— ENRD, P.O. Box 7611, Washington, DC 20044–7611. Please enclose a check or money order for $26.75 (25 cents per page reproduction cost) payable to the United States Treasury. Thomas P. Carroll, Assistant Section Chief, Environmental Enforcement Section, Environment and Natural Resources Division. States et al. v. Valley Wood Preserving, Inc., et al., Civil Action No. 1:94–cv– 05984. This case involves claims under CERCLA relating to the costs of remediating soil and groundwater contamination at the Valley Wood Preserving Site in Turlock, California (the ‘‘Site’’). Under the proposed Consent Decree, Valley Wood Preserving, Inc. agrees to conduct the remaining cleanup work at the Site and to pay EPA’s future response costs incurred in connection with the Site. In exchange, Valley Wood Preserving, Inc. receives a covenant not to sue under Sections 106 and 107 of CERCLA and Section 7003 of the Resource Conservation and Recovery Act (‘‘RCRA’’). A group of current and former shareholders and employees of Valley Wood Preserving, Inc.—Lynn Shurtliff, Edgar J. Langley, Cordes J. Langley, Catherine E.L. Elawadly, Edith E.. Langley, Joyce Logsdon, the Estate of Michael H. Logsdon, the Marie J. Langley Revocable Trust, and Robert Schmidt—are also parties to the proposed Consent Decree, and also receive covenants not to sue under CERCLA and RCRA. The publication of this notice opens a period for public comment on the proposed Consent Decree. Comments should be addressed to the Assistant Attorney General, Environment and Natural Resources Division, and should refer to United States, et al. v. Valley Wood Preserving, Inc., et al., D.J. Ref. No. 90–11–3–835. All comments must be submitted no later than thirty (30) days after the publication date of this notice. Comments may be submitted either by email or by mail: To submit comments: Send them to: By email ....... pubcomment-ees.enrd@ usdoj.gov. Assistant Attorney General, U.S. DOJ—ENRD, P.O. Box 7611, Washington, DC 20044–7611. By mail ......... [FR Doc. 2017–28164 Filed 12–28–17; 8:45 am] BILLING CODE 4410–15–P DEPARTMENT OF JUSTICE Notice of Lodging of Proposed Consent Decree Under the Comprehensive Environmental Response, Compensation, and Liability Act (‘‘CERCLA’’) On December 21, 2017, the Department of Justice lodged a proposed Consent Decree with the United States District Court for the Eastern District of California in the lawsuit entitled United PO 00000 Frm 00069 Fmt 4703 Sfmt 4703 Under section 7003(d) of RCRA, a commenter may request an opportunity for a public meeting in the affected area. During the public comment period, the proposed Consent Decree may be examined and downloaded at this Justice Department website: https:// www.justice.gov/enrd/consent-decrees. We will provide a paper copy of the proposed Consent Decree upon written request and payment of reproduction costs. Please mail your request and payment to: Consent Decree Library, U.S. DOJ—ENRD, P.O. Box 7611, Washington, DC 20044–7611. E:\FR\FM\29DEN1.SGM 29DEN1

Agencies

[Federal Register Volume 82, Number 249 (Friday, December 29, 2017)]
[Notices]
[Pages 61795-61796]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-28177]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Bulk Manufacturer of Controlled Substances Application: Cambrex 
High Point, Inc.

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before February 27, 2018.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DRW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION:  The Attorney General has delegated his 
authority under the Controlled Substances Act to the Administrator of 
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority 
to exercise all necessary functions with respect to the promulgation 
and implementation of 21 CFR part 1301, incident to the registration of 
manufacturers, distributors, dispensers, importers, and exporters of 
controlled substances (other than final orders in connection with 
suspension, denial, or revocation of registration) has been redelegated 
to the Assistant Administrator of the DEA Diversion Control Division 
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, 
appendix to subpart R.
    In accordance with 21 CFR 1301.33(a), this is notice that on 
November 22, 2016, Cambrex High Point, Inc., 4180 Mendenhall Oaks 
Parkway, High Point, North Carolina 27265 applied to be registered as a 
bulk

[[Page 61796]]

manufacturer of the following basic classes of controlled substances:

------------------------------------------------------------------------
         Controlled substance           Drug code         Schedule
------------------------------------------------------------------------
Oxymorphone..........................         9652  II
Noroxymorphone.......................         9668  II
------------------------------------------------------------------------

    The company plans to manufacture the above-listed controlled 
substances in bulk for distribution to its customers.

     Dated: December 15, 2017.
Demetra Ashley,
Acting Assistant Administrator.
[FR Doc. 2017-28177 Filed 12-28-17; 8:45 am]
 BILLING CODE 4410-09-P